Extendicare, Inc.

  • Market Cap: Small Cap
  • Industry: Hospital
  • ISIN: CA30224T8639
CAD
26.43
2.28 (9.44%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

374.61 k

Shareholding (Jun 2016)

FII

0.00%

Held by 1 FIIs

DII

100.0%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

High Management Efficiency with a high ROCE of 21.54%

 
2

High Debt Company with a Debt to Equity ratio (avg) at times

3

Poor long term growth as Net Sales has grown by an annual rate of 6.00% and Operating profit at 27.43% over the last 5 years

 
4

The company has declared Positive results for the last 6 consecutive quarters

5

With ROE of 60.73%, it has a expensive valuation with a 7.37 Price to Book Value

6

Market Beating Performance

stock-summaryMojo Parameters

Mojo Parameters

Stock DNA

stock-summary
Industry

Hospital

stock-summary
Market cap

CAD 2,281 Million (Small Cap)

stock-summary
P/E

14.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.94

stock-summary
Return on Equity

60.98%

stock-summary
Price to Book

13.92

Revenue and Profits:
Net Sales:
440 Million
(Quarterly Results - Sep 2025)
Net Profit:
24 Million
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
25.92%
0%
25.92%
6 Months
101.76%
0%
101.76%
1 Year
127.26%
0%
127.26%
2 Years
283.04%
0%
283.04%
3 Years
302.28%
0%
302.28%
4 Years
246.4%
0%
246.4%
5 Years
298.04%
0%
298.04%

Extendicare, Inc. for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions

News

Icon
No Recent News for the Company

Announcements stock-summary

Icon
No announcement available

Corporate Actions stock-summary

Icon
No corporate action available
stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
6.85%
EBIT Growth (5y)
11.52%
EBIT to Interest (avg)
3.29
Debt to EBITDA (avg)
2.33
Net Debt to Equity (avg)
1.31
Sales to Capital Employed (avg)
3.42
Tax Ratio
23.92%
Dividend Payout Ratio
53.75%
Pledged Shares
0
Institutional Holding
0.04%
ROCE (avg)
21.54%
ROE (avg)
32.54%

Valuation key factors

Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
8.31
EV to EBIT
11.70
EV to EBITDA
8.99
EV to Capital Employed
5.02
EV to Sales
0.90
PEG Ratio
0.41
Dividend Yield
NA
ROCE (Latest)
42.90%
ROE (Latest)
60.73%

Technicals key factors

Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Bullish
Bullish
OBV
Mildly Bearish
Bullish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Jun 2016stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 1 Foreign Institutions (0.0%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 22.61% vs 11.35% in Sep 2024",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Sep 2025 is 47.85% vs 38.14% in Sep 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'25",
        "Sep'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "440.30",
          "val2": "359.10",
          "chgp": "22.61%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "50.80",
          "val2": "36.10",
          "chgp": "40.72%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "5.00",
          "val2": "5.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "-3.50",
          "val2": "-1.10",
          "chgp": "-218.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "24.10",
          "val2": "16.30",
          "chgp": "47.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "92.60%",
          "val2": "75.70%",
          "chgp": "1.69%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 12.35% vs 6.83% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 121.18% vs 855.56% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,466.20",
          "val2": "1,305.00",
          "chgp": "12.35%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "144.50",
          "val2": "95.20",
          "chgp": "51.79%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "21.10",
          "val2": "21.20",
          "chgp": "-0.47%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-8.70",
          "val2": "-11.80",
          "chgp": "26.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "75.20",
          "val2": "34.00",
          "chgp": "121.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "75.70%",
          "val2": "48.00%",
          "chgp": "2.77%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Sep'25 - YoYstock-summary

Sep'25
Sep'24
Change(%)
Net Sales
440.30
359.10
22.61%
Operating Profit (PBDIT) excl Other Income
50.80
36.10
40.72%
Interest
5.00
5.00
Exceptional Items
-3.50
-1.10
-218.18%
Consolidate Net Profit
24.10
16.30
47.85%
Operating Profit Margin (Excl OI)
92.60%
75.70%
1.69%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in quarter ended Sep 2025 is 22.61% vs 11.35% in Sep 2024

Direction Arrows
Consolidated Net Profit

YoY Growth in quarter ended Sep 2025 is 47.85% vs 38.14% in Sep 2024

Annual Results Snapshot (Consolidated) - Dec'24stock-summary

Dec'24
Dec'23
Change(%)
Net Sales
1,466.20
1,305.00
12.35%
Operating Profit (PBDIT) excl Other Income
144.50
95.20
51.79%
Interest
21.10
21.20
-0.47%
Exceptional Items
-8.70
-11.80
26.27%
Consolidate Net Profit
75.20
34.00
121.18%
Operating Profit Margin (Excl OI)
75.70%
48.00%
2.77%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2024 is 12.35% vs 6.83% in Dec 2023

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2024 is 121.18% vs 855.56% in Dec 2023

stock-summaryCompany CV
About Extendicare, Inc. stock-summary
stock-summary
Extendicare, Inc.
Hospital
Extendicare Inc. is a Canada-based company that offers senior care across Canada. The Company’s segments include long-term care (LTC); retirement living; home health care; other Canadian operations and Remaining U.S. The long-term care segment owns and operates LTC centers, inclusive of a standalone designated supportive living center and a designated supportive living wing in Alberta, and retirement wings in Ontario. The retirement living segment owns and operates retirement living communities under the Esprit Lifestyle Communities brand. The home health care segment provides home health care services through ParaMed. The Company’s other Canadian operations are composed of its contract services and consulting provided by Extendicare Assist and its purchasing services. The Remaining U.S segment consists of its wholly owned Bermuda based captive insurance company, Laurier Indemnity Company, Ltd.
Company Coordinates stock-summary
Company Details
3000 Steeles Ave E Suite 700 , MARKHAM ON : L3R 9W2
stock-summary
Tel: 1 905 47055341 905 4705534
stock-summary
Registrar Details